Literature DB >> 25411434

Adjuvant treatment for post-operative head and neck squamous cell carcinoma.

Naomi Kiyota1, Makoto Tahara2, Masato Fujii3.   

Abstract

One of the mainstays of treatment for locally advanced head and neck squamous cell carcinoma is surgery. However, for post-operative patients with high-risk factors for recurrence, surgery alone is insufficient and improving survival requires adjuvant treatment after surgery. Unlike with most other malignancies, the standard adjuvant treatment for post-operative head and neck cancer patients with high-risk factors for recurrence is radiotherapy concurrent with chemotherapy. This review article focuses on the history and future perspectives of adjuvant treatment for post-operative head and neck squamous cell carcinoma.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  adjuvant treatment; chemoradiotherapy; head and neck cancer; high-risk factors for recurrence

Mesh：

Substances：

Year:  2014        PMID： 25411434     DOI： 10.1093/jjco/hyu195

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


  7 in total

1.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

2.  Jak3 is involved in CCR7-dependent migration and invasion in metastatic squamous cell carcinoma of the head and neck.

Authors:  Zhongti Zhang; Fayu Liu; Zhenning Li; Dan Wang; Ruiwu Li; Changfu Sun
Journal:  Oncol Lett       Date:  2017-03-14       Impact factor: 2.967

Review 3.  Exosomal microRNAs (exoMIRs): micromolecules with macro impact in oral cancer.

Authors:  Rajib Dhar; Saurav Mallik; Arikketh Devi
Journal:  3 Biotech       Date:  2022-06-26       Impact factor: 2.893

4.  Retrospective analysis of adjuvant radiotherapy in oral cavity or oropharyngeal cancer: Feasibility of omitting lower-neck irradiation.

Authors:  Sheng-Yow Ho; Wan-Chen Kao; Sheng-Yen Hsiao; Sheng-Fu Chiu; Sung-Wei Lee; Jia-Chun Chen; Li-Tsun Shieh
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

5.  CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells.

Authors:  Hiroaki Miyazaki; Ryou-U Takahashi; Marta Prieto-Vila; Yumi Kawamura; Seiji Kondo; Tatsuo Shirota; Takahiro Ochiya
Journal:  Oncotarget       Date:  2018-01-13

6.  Cytoglobin protects cancer cells from apoptosis by regulation of mitochondrial cardiolipin.

Authors:  Lorna S Thorne; Garret Rochford; Timothy D Williams; Andrew D Southam; Giovanny Rodriguez-Blanco; Warwick B Dunn; Nikolas J Hodges
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

7.  Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).

Authors:  Matthias Balk; Robin Rupp; Konstantin Mantsopoulos; Moritz Allner; Philipp Grundtner; S K Mueller; Maximilian Traxdorf; Markus Eckstein; Stefan Speer; Sabine Semrau; Rainer Fietkau; Heinrich Iro; Markus Hecht; Antoniu-Oreste Gostian
Journal:  BMC Cancer       Date:  2021-11-18       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.